381 related articles for article (PubMed ID: 31442267)
1. Long-term outcomes of patients with end-stage kidney disease due to membranous nephropathy: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry.
Yang WL; Bose B; Zhang L; Mcstea M; Cho Y; Fahim M; Hawley CM; Pascoe EM; Johnson DW
PLoS One; 2019; 14(8):e0221531. PubMed ID: 31442267
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcomes of patients with end-stage kidney disease due to membranoproliferative glomerulonephritis: an ANZDATA registry study.
Wilson GJ; Cho Y; Teixiera-Pinto A; Isbel N; Campbell S; Hawley C; Johnson DW
BMC Nephrol; 2019 Nov; 20(1):417. PubMed ID: 31752734
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of end-stage kidney disease for patients with IgA nephropathy: A multi-centre registry study.
Zhang L; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; De Zoysa J; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Nephrology (Carlton); 2016 May; 21(5):387-96. PubMed ID: 26393772
[TBL] [Abstract][Full Text] [Related]
4. End-Stage Kidney Disease Due to Fibrillary Glomerulonephritis and Immunotactoid Glomerulopathy - Outcomes in 66 Consecutive ANZDATA Registry Cases.
Mallett A; Tang W; Hart G; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Clayton PA; Johnson DW
Am J Nephrol; 2015; 42(3):177-84. PubMed ID: 26418732
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of end-stage kidney disease for patients with lupus nephritis.
Zhang L; Lee G; Liu X; Pascoe EM; Badve SV; Boudville NC; Clayton PA; Hawley CM; Kanellis J; McDonald SP; Peh CA; Polkinghorne KR; Johnson DW
Kidney Int; 2016 Jun; 89(6):1337-45. PubMed ID: 27165824
[TBL] [Abstract][Full Text] [Related]
6. End-stage kidney disease due to Alport syndrome: outcomes in 296 consecutive Australia and New Zealand Dialysis and Transplant Registry cases.
Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW
Nephrol Dial Transplant; 2014 Dec; 29(12):2277-86. PubMed ID: 25061124
[TBL] [Abstract][Full Text] [Related]
7. The outcomes of patients with kidney failure due to focal segmental glomerulosclerosis (FSGS) in Australia and New Zealand: A cohort study using the Australia and New Zealand Dialysis and Transplant Registry (ANZDATA).
Bose B; Milanzi E; Pascoe EM; Johnson DW; Badve SV
PLoS One; 2023; 18(11):e0293721. PubMed ID: 37917639
[TBL] [Abstract][Full Text] [Related]
8. End-stage kidney disease due to haemolytic uraemic syndrome--outcomes in 241 consecutive ANZDATA registry cases.
Tang W; Mohandas J; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
BMC Nephrol; 2012 Dec; 13():164. PubMed ID: 23206870
[TBL] [Abstract][Full Text] [Related]
9. Increased glomerulonephritis recurrence after living related donation.
Kennard AL; Jiang SH; Walters GD
BMC Nephrol; 2017 Jan; 18(1):25. PubMed ID: 28095803
[TBL] [Abstract][Full Text] [Related]
10. The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New Zealand.
Tang W; Bose B; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; Peh CA; Johnson DW
Clin J Am Soc Nephrol; 2013 May; 8(5):773-80. PubMed ID: 23349331
[TBL] [Abstract][Full Text] [Related]
11. Recurrent glomerulonephritis after kidney transplantation: risk factors and allograft outcomes.
Allen PJ; Chadban SJ; Craig JC; Lim WH; Allen RDM; Clayton PA; Teixeira-Pinto A; Wong G
Kidney Int; 2017 Aug; 92(2):461-469. PubMed ID: 28601198
[TBL] [Abstract][Full Text] [Related]
12. End-stage renal failure due to amyloidosis: outcomes in 490 ANZDATA registry cases.
Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; de Zoysa JR; Johnson DW
Nephrol Dial Transplant; 2013 Feb; 28(2):455-61. PubMed ID: 23182810
[TBL] [Abstract][Full Text] [Related]
13. Long-term outcomes of kidney transplant recipients with end-stage kidney disease attributed to presumed/advanced glomerulonephritis or unknown cause.
Lim WH; Wong G; McDonald SP; Chakera A; Luxton G; Isbel NM; Pilmore HL; Barbour T; Hughes P; Chadban SJ
Sci Rep; 2018 Jun; 8(1):9021. PubMed ID: 29899355
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease-related mortality risk.
Lim WH; Johnson DW; Hawley C; Lok C; Polkinghorne KR; Roberts MA; Boudville N; Wong G
Med J Aust; 2018 Nov; 209(10):440-446. PubMed ID: 30332936
[TBL] [Abstract][Full Text] [Related]
15. Long-term Kidney Transplant Outcomes in Primary Glomerulonephritis: Analysis From the ERA-EDTA Registry.
Pippias M; Stel VS; Aresté-Fosalba N; Couchoud C; Fernandez-Fresnedo G; Finne P; Heaf JG; Hoitsma A; De Meester J; Pálsson R; Ravani P; Segelmark M; Traynor JP; Reisæter AV; Caskey FJ; Jager KJ
Transplantation; 2016 Sep; 100(9):1955-62. PubMed ID: 26588008
[TBL] [Abstract][Full Text] [Related]
16. End-stage kidney disease due to scleroderma--outcomes in 127 consecutive ANZDATA registry cases.
Siva B; McDonald SP; Hawley CM; Rosman JB; Brown FG; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW
Nephrol Dial Transplant; 2011 Oct; 26(10):3165-71. PubMed ID: 21357212
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and clinical outcomes of patients with kidney failure of unknown aetiology from ANZDATA registry.
Wang LS; Vangaveti V; Ng MSY; Mallett AJ
PLoS One; 2024; 19(3):e0300259. PubMed ID: 38466666
[TBL] [Abstract][Full Text] [Related]
18. Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease.
Tang W; McDonald SP; Hawley CM; Badve SV; Boudville NC; Brown FG; Clayton PA; Campbell SB; de Zoysa JR; Johnson DW
Kidney Int; 2013 Mar; 83(3):503-10. PubMed ID: 23254902
[TBL] [Abstract][Full Text] [Related]
19. Effect of previously failed kidney transplantation on peritoneal dialysis outcomes in the Australian and New Zealand patient populations.
Badve SV; Hawley CM; McDonald SP; Mudge DW; Rosman JB; Brown FG; Johnson DW;
Nephrol Dial Transplant; 2006 Mar; 21(3):776-83. PubMed ID: 16280374
[TBL] [Abstract][Full Text] [Related]
20. Absolute risk and risk factors for stroke mortality in patients with end-stage kidney disease (ESKD): population-based cohort study using data linkage.
De La Mata NL; Alfaro-Ramirez M; Kelly PJ; Masson P; Al-Shahi Salman R; Webster AC
BMJ Open; 2019 Feb; 9(2):e026263. PubMed ID: 30798318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
